{"PubmedArticle": [{"MedlineCitation": {"SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "OtherAbstract": [], "CitationSubset": ["IM"], "KeywordList": [], "GeneralNote": [], "PMID": "10815276", "DateCompleted": {"Year": "2000", "Month": "06", "Day": "16"}, "DateRevised": {"Year": "2013", "Month": "11", "Day": "21"}, "Article": {"ArticleDate": [], "Language": ["ita"], "ELocationID": [], "Journal": {"ISSN": "1129-4728", "JournalIssue": {"Volume": "1", "Issue": "3", "PubDate": {"Year": "2000", "Month": "Mar"}}, "Title": "Italian heart journal. Supplement : official journal of the Italian Federation of Cardiology", "ISOAbbreviation": "Ital Heart J Suppl"}, "ArticleTitle": "[Blocking of aldosterone receptors reduces the risk of events in patients with severe cardiac failure].", "Pagination": {"StartPage": "425", "EndPage": "426", "MedlinePgn": "425-6"}, "AuthorList": [{"AffiliationInfo": [{"Identifier": [], "Affiliation": "Divisione di Cardiologia, Fondazione Salvatore Maugeri, IRCCS, Centro Medico di Pavia."}], "Identifier": [], "LastName": "Opasich", "ForeName": "C", "Initials": "C"}], "PublicationTypeList": ["Clinical Trial", "Journal Article", "Multicenter Study", "Randomized Controlled Trial"], "VernacularTitle": "Il blocco dei recettori dell'aldosterone riduce il rischio di eventi nei pazienti con scompenso cardiaco cronico severo."}, "MedlineJournalInfo": {"Country": "Italy", "MedlineTA": "Ital Heart J Suppl", "NlmUniqueID": "101223651", "ISSNLinking": "1129-4728"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Angiotensin-Converting Enzyme Inhibitors"}, {"RegistryNumber": "0", "NameOfSubstance": "Diuretics"}, {"RegistryNumber": "0", "NameOfSubstance": "Mineralocorticoid Receptor Antagonists"}, {"RegistryNumber": "27O7W4T232", "NameOfSubstance": "Spironolactone"}], "MeshHeadingList": [{"QualifierName": ["therapeutic use"], "DescriptorName": "Angiotensin-Converting Enzyme Inhibitors"}, {"QualifierName": [], "DescriptorName": "Digitalis"}, {"QualifierName": ["therapeutic use"], "DescriptorName": "Diuretics"}, {"QualifierName": [], "DescriptorName": "Double-Blind Method"}, {"QualifierName": [], "DescriptorName": "Drug Therapy, Combination"}, {"QualifierName": [], "DescriptorName": "Follow-Up Studies"}, {"QualifierName": ["drug therapy", "mortality"], "DescriptorName": "Heart Failure"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": ["therapeutic use"], "DescriptorName": "Mineralocorticoid Receptor Antagonists"}, {"QualifierName": [], "DescriptorName": "Plants, Medicinal"}, {"QualifierName": [], "DescriptorName": "Plants, Toxic"}, {"QualifierName": [], "DescriptorName": "Risk Factors"}, {"QualifierName": ["therapeutic use"], "DescriptorName": "Spironolactone"}, {"QualifierName": [], "DescriptorName": "Time Factors"}]}, "PubmedData": {"ReferenceList": [], "History": [{"Year": "2000", "Month": "5", "Day": "18", "Hour": "9", "Minute": "0"}, {"Year": "2000", "Month": "6", "Day": "24", "Hour": "11", "Minute": "0"}, {"Year": "2000", "Month": "5", "Day": "18", "Hour": "9", "Minute": "0"}], "PublicationStatus": "ppublish", "ArticleIdList": ["10815276"]}}], "PubmedBookArticle": []}